Background. End-stage renal disease is known to disrupt the cell-mediated immune response that is responsible for the killing of intracellular organisms such as Mycobacterium tuberculosis. Risk factors that contribute to the development of tuberculosis (TB) disease in the US dialysis population have not been studied on a large scale. Methods. A retrospective cohort study of TB disease in 272 024 patients in the US Renal Data System initiated on dialysis therapy between 1 April 1995 and 31 December 1999 with Medicare or Medicaid as primary payer were analysed. A total of 21 risk factors were analysed. Results. Among the US population studied, there is a 1.2 and 1.6 % cumulative incidence of TB in patients undergoing either peritoneal or haem...
Tuberculosis has been paid more attention in recent years because of the increase in the number of p...
AbstractEnd-stage renal disease (ESRD) patients are vulnerable to Mycobacterium tuberculosis (MTB) i...
AIM: Our aim was threefold: first, to determine the incidence of active TB in our cohort, second to ...
Background. End-stage renal disease is known to disrupt the cell-mediated immune response that is re...
BACKGROUND: The ability to identify individuals at increased risk of developing tuberculosis (TB) ha...
OBJECTIVES The risk of developing active TB is greater in those receiving haemodialysis. This stu...
Background: Patients with chronic kidney disease (CKD) receiving maintenance renal replacement thera...
Patients with renal failure are vulnerable to tuberculosis, a common worldwide infectious disease. I...
Patients with renal failure are vulnerable to tuberculosis, a common worldwide infectious disease. I...
Extent: 6p.BACKGROUND: The ability to identify individuals at increased risk of developing tuberculo...
Background: Tuberculosis is a common infectious disease in long-term dialysis patients. The prevalen...
BACKGROUND: Tuberculosis is a common infectious disease in long-term dialysis patients. The prevalen...
The incidence of active TB and attendant mortality is increased in patients with impaired cellular i...
Background: Profound alterations in immune responses associated with uremia and exacerbated by dialy...
Patients on long-term dialysis are at high risk for tuberculosis (TB). Although latent tuberculosis ...
Tuberculosis has been paid more attention in recent years because of the increase in the number of p...
AbstractEnd-stage renal disease (ESRD) patients are vulnerable to Mycobacterium tuberculosis (MTB) i...
AIM: Our aim was threefold: first, to determine the incidence of active TB in our cohort, second to ...
Background. End-stage renal disease is known to disrupt the cell-mediated immune response that is re...
BACKGROUND: The ability to identify individuals at increased risk of developing tuberculosis (TB) ha...
OBJECTIVES The risk of developing active TB is greater in those receiving haemodialysis. This stu...
Background: Patients with chronic kidney disease (CKD) receiving maintenance renal replacement thera...
Patients with renal failure are vulnerable to tuberculosis, a common worldwide infectious disease. I...
Patients with renal failure are vulnerable to tuberculosis, a common worldwide infectious disease. I...
Extent: 6p.BACKGROUND: The ability to identify individuals at increased risk of developing tuberculo...
Background: Tuberculosis is a common infectious disease in long-term dialysis patients. The prevalen...
BACKGROUND: Tuberculosis is a common infectious disease in long-term dialysis patients. The prevalen...
The incidence of active TB and attendant mortality is increased in patients with impaired cellular i...
Background: Profound alterations in immune responses associated with uremia and exacerbated by dialy...
Patients on long-term dialysis are at high risk for tuberculosis (TB). Although latent tuberculosis ...
Tuberculosis has been paid more attention in recent years because of the increase in the number of p...
AbstractEnd-stage renal disease (ESRD) patients are vulnerable to Mycobacterium tuberculosis (MTB) i...
AIM: Our aim was threefold: first, to determine the incidence of active TB in our cohort, second to ...